| Application no. and date | 19758589.6 (espacenet) (Federated) (European Patent Register), 20190809 | | Patent/reg. no. and date | DK/EP 4010322, 20251105 | | Publication date | 20220615 | | Priority no. and date | | | EP pub. no. and date |
EP 4010322 20220615 | | Effective date | | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US | | Applicant ref. no. | V498793DK00 | | Inventor | GREER, Elaine, c/o Pfizer Inc. 445 Eastern Point Road
Groton, Connecticut 06340, US,
ANDERSON, Stephen, 57 Whittaker Dr.
Stonington, Connecticut 06378, US,
MALONEY, Mark, c/o Pfizer Inc. 445 Eastern Point Road
Groton, Connecticut 06340, US,
YU, Shu, c/o Pfizer Inc. 445 Eastern Point Road
Groton, Connecticut 06340, US,
ALBERT, Ekaterina, 821 Lagrange St.
West Lafayette, Indiana 47906, US,
RIGSBEE, Emily, c/o Albany Molecular Research, Inc.
3065 Kent Avenue
West Lafayette, Indiana 47906, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/4164 (2006.01) , A61P 35/00 (2006.01) , C07D 233/88 (2006.01) | | Title | FASTE FORMER AF (S)-2-(((S)-6,8-DIFLUORO-1,2,3,4-TETRAHYDRONAPHTHALEN-2-YL) AMINO)-N-(1-(2-METHYL-1-(NEOPENTYLAMINO)PROPAN-2-YL)-1H-IMIDAZOL-4-YL)PENTANAMID OG ANVENDELSER HERAF | | Int. application no. | US2019045948 | | Int. publication no. | WO2021029854 | | Related patent (certificate) | CA 2026 00017 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
